Universal- Versus Guidelines-Directed Genetic Testing for Germline Pathogenic Variants Utilizing a Multi-Gene Panel for Inherited Cancers in Non-Western Society.
Clinical trial NCT04920513 · COMPLETED
Trial details
- NCT number
- NCT04920513
- Sponsor
- King Hussein Cancer Center
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-05-01
- Primary completion
- 2025-02-01
- Enrollment
- 3000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.